StockSelector.com
  Research, Select, & Monitor Thursday, April 26, 2018 3:08:54 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Concert Pharmaceuticals Inc.$18.86$.201.07%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Concert Pharmaceuticals Inc. has an overall rank of 2671 out of 6913 stocks based on 9 positive rankings and 8 negative rankings.

Positive Rankings
Highest ROA
Concert Pharmaceuticals Inc. rank is 38
Highest Net Margin
Concert Pharmaceuticals Inc. rank is 89
Debt-to-Equity
Concert Pharmaceuticals Inc. rank is 116
Highest ROE
Concert Pharmaceuticals Inc. rank is 148
Historic Revenue Growth
Concert Pharmaceuticals Inc. rank is 151
Target Prices
The average analysts' target price is $27.00 for Concert Pharmaceuticals Inc. using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Concert Pharmaceuticals Inc. is ranked 260.
Low Put/Call
Concert Pharmaceuticals Inc. has a low Put/Call ratio of 0.24 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Concert Pharmaceuticals Inc. is ranked 597.
Highest Cash Growth
Concert Pharmaceuticals Inc. rank is 935
Oversold Stochastics
Concert Pharmaceuticals Inc. rank is 1079
Negative Rankings
Negative Revenue Estimate
Concert Pharmaceuticals Inc. rank is 2
Negative EPS Growth
Concert Pharmaceuticals Inc. rank is 9
90 Day Loss
Concert Pharmaceuticals Inc. rank is 386
Down EPS Surprise
Concert Pharmaceuticals Inc. missed the consensus earnings estimate when it last reported quarterly earnings.
10 Day Loss
Concert Pharmaceuticals Inc. rank is 966
High vPut/Call
Concert Pharmaceuticals Inc. has a high Put/Call ratio of 0.86 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Concert Pharmaceuticals Inc. is ranked 1300.
Price-to-Sales
Concert Pharmaceuticals Inc. rank is 1919
Price-to-Book
Concert Pharmaceuticals Inc. rank is 2254







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.